JOHNSON & JOHNSON Long-Term Concentrated

Location: New Brunswick, NJ

CIK: 0000200406 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Mar 18, 2026

Total Value: $504M (100.0% shares, 0.0% debt)

Holdings (20)

PTGX Protagonist Therapeutics Inc. 32.3%

Value $163M Shares 2,449,183 Est. Cost $42.63 Unrealized +33.3%

NBTX Nanobiotix S.A. 21.1%

Value $106M Shares 5,623,816 Est. Cost $7.53 Unrealized —

MGTX MeiraGTx Holdings plc 10.8%

Value $54.66M Shares 6,641,064 Est. Cost $9.84 Unrealized -19.7%

RAPP Rapport Therapeutics, Inc. 10.5%

Value $53M Shares 1,784,517 Est. Cost $23.15 Unrealized -23.0%

CVRX CVRx, Inc. 6.6%

Value $33.11M Shares 4,103,430 Est. Cost $19.85 Unrealized -62.1%

LEGN Legend Biotech Corporation 5.3%

Value $26.56M Shares 814,586 Est. Cost $50.56 Unrealized —

CTNM Contineum Therapeutics Inc. 4.6%

Value $23.26M Shares 1,979,173 Est. Cost $16.10 Unrealized -49.9%

PRCT Procept BioRobotics Corporation 2.5%

Value $12.77M Shares 357,939 Est. Cost $38.38 Unrealized +19.0%

XNCR Xencor, Inc. 1.7%

Value $8.775M Shares 748,062 Est. Cost $37.91 Unrealized -77.1%

ARWR Arrowhead Pharmaceuticals, Inc. 1.7%

Value $8.54M Shares 247,598 Est. Cost $64.75 Unrealized -66.0%

FATE Fate Therapeutics, Inc. 0.8%

Value $4.258M Shares 3,379,064 Est. Cost $78.44 Unrealized -98.6%

NMRA Neumora Therapeutics, Inc. 0.7%

Value $3.366M Shares 1,849,445 Est. Cost $12.57 Unrealized -87.1%

— Vor Biopharma, Inc. 0.5%

Value $2.618M Shares 53,732 Est. Cost $15.68 Unrealized —

— Rallybio Corporation 0.4%

Value $1.815M Shares 3,636,363 Est. Cost $1.34 Unrealized —

LYEL Lyell Immunopharma Inc. 0.2%

Value $891K Shares 54,887 Est. Cost $11.42 Unrealized 0.0%

NNOX Nano-X Imaging Ltd. 0.1%

Value $588K Shares 158,852 Est. Cost $15.61 Unrealized -71.5%

LAB Standard BioTools Inc 0.1%

Value $406K Shares 311,967 Est. Cost $2.41 Unrealized -45.7%

— Adicet Bio, Inc. 0.1%

Value $295K Shares 364,472 Est. Cost $7.84 Unrealized —

— BiomX Inc. 0.0%

Value $50,855 Shares 96,866 Est. Cost $3.06 Unrealized —

— Senseonics Holdings, Inc. 0.0%

Value $23,804 Shares 54,621 Est. Cost $3.39 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
PTGX	Protagonist Therapeutics Inc.	2,449,183	$163M	32.3%	$42.63	+33.3%	COM	74366E102
NBTX	Nanobiotix S.A.	5,623,816	$106M	21.1%	$7.53	—	SPONSORED ADS	63009J107
MGTX	MeiraGTx Holdings plc	6,641,064	$54.66M	10.8%	$9.84	-19.7%	COM	G59665102
RAPP	Rapport Therapeutics, Inc.	1,784,517	$53M	10.5%	$23.15	-23.0%	COM	75383L102
CVRX	CVRx, Inc.	4,103,430	$33.11M	6.6%	$19.85	-62.1%	COM	126638105
LEGN	Legend Biotech Corporation	814,586	$26.56M	5.3%	$50.56	—	SPONSORED ADS	52490G102
CTNM	Contineum Therapeutics Inc.	1,979,173	$23.26M	4.6%	$16.10	-49.9%	CL A	21217B100
PRCT	Procept BioRobotics Corporation	357,939	$12.77M	2.5%	$38.38	+19.0%	COM	74276L105
XNCR	Xencor, Inc.	748,062	$8.775M	1.7%	$37.91	-77.1%	COM	98401F105
ARWR	Arrowhead Pharmaceuticals, Inc.	247,598	$8.54M	1.7%	$64.75	-66.0%	COM	04280A100
FATE	Fate Therapeutics, Inc.	3,379,064	$4.258M	0.8%	$78.44	-98.6%	COM	31189P102
NMRA	Neumora Therapeutics, Inc.	1,849,445	$3.366M	0.7%	$12.57	-87.1%	COM	640979100
—	Vor Biopharma, Inc.	53,732	$2.618M	0.5%	$15.68	—	COM	929033108
—	Rallybio Corporation	3,636,363	$1.815M	0.4%	$1.34	—	COM	75120L100
LYEL	Lyell Immunopharma Inc.	54,887	$891K	0.2%	$11.42	0.0%	COM	55083R203
NNOX	Nano-X Imaging Ltd.	158,852	$588K	0.1%	$15.61	-71.5%	ORD SHS	M70700105
LAB	Standard BioTools Inc	311,967	$406K	0.1%	$2.41	-45.7%	COM	34385P108
—	Adicet Bio, Inc.	364,472	$295K	0.1%	$7.84	—	COM	007002108
—	BiomX Inc.	96,866	$50,855	0.0%	$3.06	—	COM	09090D103
—	Senseonics Holdings, Inc.	54,621	$23,804	0.0%	$3.39	—	COM	81727U105